The retrospective analysis of nephrotoxicity for cisplatin dose of CRT compared 100mg/m2 to 80mg/m2 for head and neck cancer (HNC) patients

Authors :: Kenji Nakano
Makiko Ono
Naoki Fukuda
Mayu Yunokawa
Tomoyo Oguri
Takashi Toshiyasu
Junichi Tomomatsu
Masatoshi Nishizawa
Kuniki Kawaguchi
Shinichiro Taira
Hiroki Mitani
Tetsuya Urasaki
Shunji Takahashi
Source :: Journal of Clinical Oncology. 36:e18067-e18067
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e18067Background: Concurrent chemoradiotherapy (CRT) with single agent cisplatin for patients with head and neck cancers (HNC) have been used as the standard treatment for a long time. Although rec...

Subjects :: Oncology
Cisplatin
Cancer Research
medicine.medical_specialty
business.industry
Standard treatment
Head and neck cancer
medicine.disease
Nephrotoxicity
Concurrent chemoradiotherapy
Internal medicine
Cisplatin Dose
Retrospective analysis
Medicine
business
Head and neck
medicine.drug

Full Text Access

Tools